Skip to content

About
Support
News
Contact
EN
- NL
- DE

About
Support
News
Contact
EN
- NL
- DE

About
Support
News
Contact
EN
- NL
- DE

About
Support
News
Contact
EN
- NL
- DE

April 19, 2023

Meet Sharon, a Kaleidoer whose journey with diabetes and the Kaleido pump inspires freedom and better control.

Kaleidoer in the Spotlight: Sharon

Kaleido / 19 April 2023

Getting her diagnosis was a life-changing moment for Sharon, who was in her 20s when she found out she had […]

Careers

Jobs
About

Support

FAQ
Contact

Contact Kaleido Care

hello@hellokaleido.com
+31 (0) 800 19 10

Copyright 2025 ViCentra B.V. All rights reserved | 920048-10 | Privacy & Cookies Policy | Terms of Use | Declaration of conformity

1. Discuss with your Healthcare professional
2. Compared to the standard therapy in this study; Benhamou P-Y, Adenis A, Lablanche S, et al. First Generation of a Modular Interoperable Closed-Loop System for Automated Insulin Delivery in Patients With Type 1 Diabetes: Lessons From Trials and Real-Life Data. Journal of Diabetes Science and Technology. 2023;0(0). doi:10.1177/19322968231186976

YourLoops, and DBLG1 are either registered trademarks or trademarks of Diabeloop SA in Europe and/or in other countries. Dexcom® and Dexcom G6® are registered trademarks of Dexcom, Inc. in the United States and/or other countries. DBLG1 System is available only on prescription. DBLG1 System is indicated for Adults only. DBLG1 System is a CE 0123 marked medical device (except for configurations used exclusively during clinical investigations). Illustrations may vary depending on DBLG1 System configurations. Please be reminded that the User Manual for the medical device serves as the primary document for ensuring the safe operation of the system. Illustrations may differ from the actual product.

1. Discuss with your Healthcare professional
2. compared to the standard therapy in this study; Benhamou P-Y, Adenis A, Lablanche S, et al. First Generation of a Modular Interoperable Closed-Loop System for Automated Insulin Delivery in Patients With Type 1 Diabetes: Lessons From Trials and Real-Life Data. Journal of Diabetes Science and Technology. 2023;0(0). doi:10.1177/19322968231186976

YourLoops, and DBLG1 are either registered trademarks or trademarks of Diabeloop SA in Europe and/or in other countries. Dexcom® and Dexcom G6® are registered trademarks of Dexcom, Inc. in the United States and/or other countries. DBLG1 System is available only on prescription. DBLG1 System is indicated for Adults only. DBLG1 System is a CE 0123 marked medical device (except for configurations used exclusively during clinical investigations). Illustrations may vary depending on DBLG1 System configurations. Please be reminded that the User Manual for the medical device serves as the primary document for ensuring the safe operation of the system. Illustrations may differ from the actual product.

Careers

Jobs
About

Support

FAQ
Contact

Contact Kaleido Care

hello@hellokaleido.com
+44 (0) 808 189 21 46

Copyright 2025 ViCentra B.V. All rights reserved | 920048-10 | Privacy & Cookies Policy | Terms of Use | Declaration of conformity

Scroll to Top